While the drugmaker reaffirmed its 2025 revenue guidance of $61bn to $64bn, it raised its full-year 2025 profit outlook. Pfizer now expects to earn $2.90 to $3.10 per share, compared with its previous ...

Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that David Simmons has been appointed as the newest ...

R. Michael Alvarez, Caltech's Flintridge Foundation Professor of Political and Computational Social Science, has won the Society for Political ...

BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors.

The Trump administration is planning to pilot covering weight loss drugs. A longtime healthcare exec moves to a strategic advisory role at General Catalyst.

The antibody discovery market is expanding, driven by the increasing incidence of chronic conditions such as cancer, diabetes, and cardiovascular and ...

The International Chamber of Commerce (ICC), the world business organization representing more than 4.5-million-member ...

HBCU Fellow Tre’von Conner shares how the IKNS curriculum at Columbia is helping him learn how to effectively tackle ...

SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those ...